Barry Hatt is the Chief Operating Officer of Global Consolidated Aesthetics Ltd.GCAL is a leading provider of medical devices designed for breast aesthetics. In the role of COO, he oversees the Sales and Marketing, Finance and Technical Operations of GCAL. He additionally serves as President of Eurosilicone SAS (France)and Managing Director of Nagor Ltd (UK).He has over 30 years experience working with Medical Device and Pharmaceutical companies including Bristol Myers Squibb, Warner-Lambert and Inamed. He graduated from University College Dublin with a B.Sc. (1977) and Ph. D (1981) and lives in Ireland where GCAL is headquartered.